SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-019038
Filing Date
2022-07-12
Accepted
2022-07-12 06:10:16
Documents
14
Period of Report
2022-07-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35421
2 ex99-1.htm EX-99.1 7830
3 ex99-1_001.jpg GRAPHIC 24660
  Complete submission text file 0001493152-22-019038.txt   253764

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT glsi-20220712.xsd EX-101.SCH 2998
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT glsi-20220712_lab.xml EX-101.LAB 34240
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT glsi-20220712_pre.xml EX-101.PRE 22385
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3716
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39555 | Film No.: 221078151
SIC: 2834 Pharmaceutical Preparations